Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Journal of Clinical Gastroenterology
|
December 1, 1988
Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial
F Baldi, G Bianchi Porro, G Dobrilla, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 2, 2013
CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth
Tai Young Kim, Sarah Jackson, Yue Xiong, et al.
Oncotarget
|
September 10, 2021
The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series
Kevin Drenner, Gargi D Basu, Laurie J Goodman, et al.
Breast Cancer Research : BCR
|
January 20, 2026
Characterization of ESR1 alterations in patients with breast and gynecologic cancers
Gargi D Basu, Paige E Innis, Angela K Deem, et al.
Oncotarget
|
July 25, 2025
Comprehensive genomic profiling of over 10,000 advanced solid tumors
Jean-Paul De La O, Jess R Hoag, Angela K Deem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2025
A Concordance Study among 26 NGS Laboratories Participating in the NCI Molecular Analysis for Therapy Choice Clinical Trial
Linda K Zane, Laura M Yee, Ting-Chia Chang, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Journal of Clinical Gastroenterology
|
December 1, 1988
Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial
F Baldi, G Bianchi Porro, G Dobrilla, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 2, 2013
CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth
Tai Young Kim, Sarah Jackson, Yue Xiong, et al.
Oncotarget
|
September 10, 2021
The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series
Kevin Drenner, Gargi D Basu, Laurie J Goodman, et al.
Breast Cancer Research : BCR
|
January 20, 2026
Characterization of ESR1 alterations in patients with breast and gynecologic cancers
Gargi D Basu, Paige E Innis, Angela K Deem, et al.
Oncotarget
|
July 25, 2025
Comprehensive genomic profiling of over 10,000 advanced solid tumors
Jean-Paul De La O, Jess R Hoag, Angela K Deem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2025
A Concordance Study among 26 NGS Laboratories Participating in the NCI Molecular Analysis for Therapy Choice Clinical Trial
Linda K Zane, Laura M Yee, Ting-Chia Chang, et al.
Page
of 2